UROCOR INKS PACT TO MATCH DIAGNOSTICS WITH THERAPEUTICS HERE’S A PIONEERING EFFORT to more closely link diagnostics and therapeutics into a single product package. UroCor, Inc. and Mallinckrodt, Inc. signed an agreement that allows Mallinckrodt to sell and distribute UroCor’s new radiation treatment for prostate cancer. UroCor’s product, ProstaSeed I-125, is a radioactive pellet used …
UroCor, Unilab, AmeriPath, MedPartners, Epitope Read More »
To access this post, you must purchase The Dark Report.